ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666571 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666571; 2) Community: the network communities that were significantly associated with the response to NSC 666571; 3) Molecule: the relationships between components within communities and NSC 666571; 4) MDR: the compounds that were significantly associated with the NSC 666571.

NSC Compound Enrichment Correlation
NSC 639511 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride 0.027843564133142 0.4594957
NSC 641052 Platinum, dichloro[(phenylmethyl)methylsulfinyl]- 1-quinolinyl-, (SP-4-1) 0.027843564133142 0.32795996
NSC 658420 Null 0.027843564133142 0.46420543
NSC 665694 2-Propen-1-one, 1-(4-hydroxyphenyl)- 3-[4-(dimethylamino)phenyl]- 0.027843564133142 0.58483434
NSC 8120 Claviform 0.0278435641331422 0.3831707
NSC 685503 Propanedinitrile, [5-amino-3,6-dicyano-1,2,4-trihydro-11b-methyl- [1]benzopyrano[2,3,4-de][1,6]naphthyridin-2-ylidene- 0.0304779558345021 0.18126383
NSC 150014 Hydrazine dihydrogen sulfate salt 0.0306776553926119 0.22679674
NSC 2805 2,2',5,5'-Tetrahydroxy-4,4'-dimethylbiphenyl 0.0306776553926119 0.27540271
NSC 332837 Carbamothioic acid, dimethyl-, S-[2-(2,6-dichlorophenyl)-1-oxo-1H-inden-3-yl] ester 0.0306776553926119 0.24703409
NSC 352122 Trimetrexate glucuronate 0.0306776553926119 0.31899893
Total:78  Current:47    [First] [Prev] [Next] [Last]